Militia Capital Partners LP Makes New Investment in Acadia Healthcare Company, Inc. $ACHC

Militia Capital Partners LP bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 22,400 shares of the company’s stock, valued at approximately $318,000.

A number of other large investors also recently modified their holdings of ACHC. EverSource Wealth Advisors LLC boosted its position in shares of Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after acquiring an additional 497 shares during the period. Wells Fargo & Company MN boosted its position in shares of Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after acquiring an additional 1,510 shares during the period. Bayforest Capital Ltd bought a new position in shares of Acadia Healthcare in the fourth quarter valued at approximately $52,000. GAMMA Investing LLC boosted its position in shares of Acadia Healthcare by 124.7% in the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock valued at $69,000 after acquiring an additional 2,698 shares during the period. Finally, Praxis Investment Management Inc. bought a new position in shares of Acadia Healthcare in the fourth quarter valued at approximately $170,000.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ACHC. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday. Barclays raised their price objective on shares of Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Thursday, April 30th. Cantor Fitzgerald raised their price objective on shares of Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a research report on Friday, May 1st. KeyCorp restated an “overweight” rating and issued a $30.00 price objective on shares of Acadia Healthcare in a research report on Wednesday, May 27th. Finally, UBS Group raised their price objective on shares of Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a research report on Friday, April 17th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Acadia Healthcare presently has a consensus rating of “Hold” and an average target price of $26.85.

Acadia Healthcare Stock Performance

Shares of Acadia Healthcare stock opened at $24.99 on Wednesday. Acadia Healthcare Company, Inc. has a 1 year low of $11.43 and a 1 year high of $30.20. The firm has a market cap of $2.30 billion, a PE ratio of -2.04, a PEG ratio of 8.34 and a beta of 0.69. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. The company has a 50 day simple moving average of $25.56 and a two-hundred day simple moving average of $20.18.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The business had revenue of $828.80 million during the quarter, compared to analyst estimates of $823.51 million. During the same period in the previous year, the business posted $0.40 earnings per share. Acadia Healthcare’s revenue for the quarter was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Analysts expect that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.